Cargando…

Prospects of the Use of Cell Therapy to Induce Immune Tolerance

Conditions in which abnormal or excessive immune responses exist, such as autoimmune diseases (ADs), graft-versus-host disease, transplant rejection, and hypersensitivity reactions, are serious hazards to human health and well-being. The traditional immunosuppressive drugs used to treat these condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhenkun, Liu, Xiaolong, Cao, Fenglin, Bellanti, Joseph A., Zhou, Jin, Zheng, Song Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235417/
https://www.ncbi.nlm.nih.gov/pubmed/32477335
http://dx.doi.org/10.3389/fimmu.2020.00792
_version_ 1783535963450900480
author Wang, Zhenkun
Liu, Xiaolong
Cao, Fenglin
Bellanti, Joseph A.
Zhou, Jin
Zheng, Song Guo
author_facet Wang, Zhenkun
Liu, Xiaolong
Cao, Fenglin
Bellanti, Joseph A.
Zhou, Jin
Zheng, Song Guo
author_sort Wang, Zhenkun
collection PubMed
description Conditions in which abnormal or excessive immune responses exist, such as autoimmune diseases (ADs), graft-versus-host disease, transplant rejection, and hypersensitivity reactions, are serious hazards to human health and well-being. The traditional immunosuppressive drugs used to treat these conditions can lead to decreased immune function, a higher risk of infection, and increased tumor susceptibility. As an alternative therapeutic approach, cell therapy, in which generally intact and living cells are injected, grafted, or implanted into a patient, has the potential to overcome the limitations of traditional drug treatment and to alleviate the symptoms of many refractory diseases. Cell therapy could be a powerful approach to induce immune tolerance and restore immune homeostasis with a deeper understanding of immune tolerance mechanisms and the development of new techniques. The purpose of this review is to describe the current panoramic scope of cell therapy for immune-mediated disorders, discuss the advantages and disadvantages of different types of cell therapy, and explore novel directions and future prospects for these tolerogenic therapies.
format Online
Article
Text
id pubmed-7235417
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72354172020-05-29 Prospects of the Use of Cell Therapy to Induce Immune Tolerance Wang, Zhenkun Liu, Xiaolong Cao, Fenglin Bellanti, Joseph A. Zhou, Jin Zheng, Song Guo Front Immunol Immunology Conditions in which abnormal or excessive immune responses exist, such as autoimmune diseases (ADs), graft-versus-host disease, transplant rejection, and hypersensitivity reactions, are serious hazards to human health and well-being. The traditional immunosuppressive drugs used to treat these conditions can lead to decreased immune function, a higher risk of infection, and increased tumor susceptibility. As an alternative therapeutic approach, cell therapy, in which generally intact and living cells are injected, grafted, or implanted into a patient, has the potential to overcome the limitations of traditional drug treatment and to alleviate the symptoms of many refractory diseases. Cell therapy could be a powerful approach to induce immune tolerance and restore immune homeostasis with a deeper understanding of immune tolerance mechanisms and the development of new techniques. The purpose of this review is to describe the current panoramic scope of cell therapy for immune-mediated disorders, discuss the advantages and disadvantages of different types of cell therapy, and explore novel directions and future prospects for these tolerogenic therapies. Frontiers Media S.A. 2020-05-12 /pmc/articles/PMC7235417/ /pubmed/32477335 http://dx.doi.org/10.3389/fimmu.2020.00792 Text en Copyright © 2020 Wang, Liu, Cao, Bellanti, Zhou and Zheng. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wang, Zhenkun
Liu, Xiaolong
Cao, Fenglin
Bellanti, Joseph A.
Zhou, Jin
Zheng, Song Guo
Prospects of the Use of Cell Therapy to Induce Immune Tolerance
title Prospects of the Use of Cell Therapy to Induce Immune Tolerance
title_full Prospects of the Use of Cell Therapy to Induce Immune Tolerance
title_fullStr Prospects of the Use of Cell Therapy to Induce Immune Tolerance
title_full_unstemmed Prospects of the Use of Cell Therapy to Induce Immune Tolerance
title_short Prospects of the Use of Cell Therapy to Induce Immune Tolerance
title_sort prospects of the use of cell therapy to induce immune tolerance
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235417/
https://www.ncbi.nlm.nih.gov/pubmed/32477335
http://dx.doi.org/10.3389/fimmu.2020.00792
work_keys_str_mv AT wangzhenkun prospectsoftheuseofcelltherapytoinduceimmunetolerance
AT liuxiaolong prospectsoftheuseofcelltherapytoinduceimmunetolerance
AT caofenglin prospectsoftheuseofcelltherapytoinduceimmunetolerance
AT bellantijosepha prospectsoftheuseofcelltherapytoinduceimmunetolerance
AT zhoujin prospectsoftheuseofcelltherapytoinduceimmunetolerance
AT zhengsongguo prospectsoftheuseofcelltherapytoinduceimmunetolerance